Contemporary issues in the diagnosis of oral pemphigoid: A selective review of the literature

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 88, Issue 4, 1999, Pages 424-430

  Dayan, Sharona ^a   Simmons, Raymond K ^a   Ahmed, A Razzaque ^a,b  

^a Department of Oral Medicine ^*

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BULLOUS PEMPHIGOID; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INCIDENCE; MOUTH DISEASE; MUCOUS MEMBRANE PEMPHIGOID; REVIEW;

FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INCIDENCE; MOUTH DISEASES; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGOID, BULLOUS;

EID: 0033211018     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(99)70056-9     Document Type: Article

References (51)

1. Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 1988;118:31-40.
2. Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 1998;134:465-9.
3. Jeffes EWd, Ahmed AR. Therapy of pemphigus. Clin Dermatol 1983;1:122-40.
4. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 1996;34:645-52.
5. Ahmed AR, Kurgis BS, Rogers RSD. Cicatricial pemphigoid [see comments]. J Am Acad Dermatol 1991;24:987-1001.
6. Yunis JJ, Mobini N, Yunis EJ, et al. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci U S A 1994;91:7747-51.
7. Gallagher G, Shklar G. Oral involvement in mucous membrane pemphigoid. Clin Dermatol 1987;5:18-27.
8. Truhan AP, Ahmed AR. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. Ann Allergy 1989;62:375-91.
9. Tamesis RR, Rodriguez A, Christen WG, Akova YA, Messmer E, Foster CS. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Ophthalmology 1996;103:768-75.
10. Mobini N, Nagarwalla N, Ahmed AR. Oral pemphigoid: subset of cicatricial pemphigoid? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:37-43.
11. Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases: selective review of the literature. Oral Surg Oral Med Oral Pathol 1994;77:555-71.
12. Anhalt GJ. Pemphigoid: bullous and cicatricial. Dermatol Clin 1990;8:701-16.
13. Chan LS, Yancey KB, Hammerberg C, et al. Immune-mediated subepithelial blistering diseases of mucous membranes: pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies. Arch Dermatol 1993;129:448-55.
14. Shimizu H, Masunaga T, Ishiko A, et al. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane. J Invest Dermatol 1995;104:370-3.
15. Hoang-Xuan T, Robin H, Demers PE, et al. Pure ocular cicatricial pemphigoid: a distinct immunopathologic subset of cicatricial pemphigoid. Ophthalmology 1999;106:355-61.
16. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci U S A 1996;93:14714-9.
17. Katz SI. The epidermal basement membrane zone - structure, ontogeny, and role in disease. J Am Acad Dermatol 1984;11:1025-37.
18. Yancey KB. Adhesion molecules, II: interactions of keratinocytes with epidermal basement membrane. J Invest Dermatol 1995;104:1008-14.
19. Jones J, Downer CS, Speight PM. Changes in the expression of integrins and basement membrane proteins in benign mucous membrane pemphigoid. Oral Diseases 1995;1:159-65.
20. Symington BE, Takada Y, Carter WG. Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion. J Cell Biol 1993;120:523-35.
21. Carter WG, Kaur P, Gil SG, Gahr PJ, Wayner EA. Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes. J Cell Biol 1990;111:3141-54.
22. Hertle MD, Adams JC, Watt FM. Integrin expression during human epidermal development in vivo and in vitro. Development 1991;112:193-206.
23. Sciubba JJ. Autoimmune aspects of pemphigus vulgaris and mucosal pemphigoid. Advances in Dental Research 1996;10:52-6.
24. Meyer JR, Migliorati CA, Daniels TE, Greenspan JS. Localization of basement membrane components in mucous membrane pemphigoid. J Invest Dermatol 1985;84:105-7.
25. Gately LE 3rd, Nesbitt LT Jr. Update on immunofluorescent testing in bullous diseases and lupus erythematosus. Dermatol Clin 1994;12:133-42.
26. Ahmed A. Diagnosis of bullous diseases and studies on pathogenesis of blister formation using immunopathological techniques. J Cutan Pathol 1984;111:237-48.
27. Sacks EH, Jakobiec FA, Wieczorek R, Donnenfeld E, Perry H, Knowles DM Jr. Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid: further evidence for a T cell-mediated disease. Ophthalmology 1989;96:236-43.
28. Siegel MA, Anhalt GJ. Direct immunofluorescence of detached gingival epithelium for diagnosis of cicatricial pemphigoid: report of five cases. Oral Surg Oral Med Oral Pathol 1993;75:296-302.
29. Hopkinson SB, Riddelle KS, Jones JC. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol 1992;99:264-70.
30. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest 1988;82:1864-70.
31. Klatte DH, Kurpakus MA, Grelling KA, Jones JC. Immunochemical characterization of three components of the hemidesmosome and their expression in cultured epithelial cells. J Cell Biol 1989;109:3377-90.
32. Cotell SL, Lapiere JC, Chen JD, et al. A novel 105-kDa lamina lucida autoantigen: association with bullous pemphigoid. J Invest Dermatol 1994;103:78-83.
33. Laskaris G, Angelopoulos A. Cicatricial pemphigoid: direct and indirect immunofluorescent studies. Oral Surg Oral Med Oral Pathol 1981;51:48-54.
34. Nisengard RJ, Neiders M. Desquamative lesions of the gingiva. J Periodontol 1981;52:500-10.
35. Fine JD, Neises GR, Katz SI. Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid. J Invest Dermatol 1984;82:39-43.
36. Manton SL, Scully C. Mucous membrane pemphigoid: an elusive diagnosis? Oral Surg Oral Med Oral Pathol 1988;66:37-40.
37. Domloge-Hultsch N, Anhalt GJ, Gammon WR, et al. Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorder. Arch Dermatol 1994;130:1521-9.
38. Sarret Y, Reano A, Nicolas JF, Su H, Thivolet J. Bullous pemphigoid and cicatricial pemphigoid: immunoblotting detection of involved autoantigens. Autoimmunity 1989;2:145-53.
39. Bernard P, Prost C, Durepaire N, Basset-Seguin N, Didierjean L, Saurat JH. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol 1992;99:174-9.
40. Niimi Y, Zhu XJ, Bystryn JC. Identification of cicatricial pemphigoid antigens. Arch Dermatol 1992;128:54-7.
41. Balding SD, Prost C, Diaz LA, et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 1996;106:141-6.
42. Kawahara Y, Amagai M, Ohata Y, et al. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5. J Am Acad Dermatol 1998;38:624-7.
43. Dabelsteen E. Molecular biological aspects of acquired bullous diseases. Crit Rev Oral Biol Med 1998;9:162-78.
44. Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:517-34.
45. Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 1995;105:543-8.
46. Fine JD. Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens. Collagen and Related Research 1985;5:369-77.
47. Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL. Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid. J Invest Dermatol 1996;107:136-9.
48. Chan LS, Majmudar AA, Tran HH, et al. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 1997;108:848-53.
49. Dowling J, Yu QC, Fuchs E. Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 1996;134:559-72.
50. Bedane C, McMillan JR, Balding SD, et al. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol 1997;108:901-7.
51. Laskaris G, Sklavounou A, Stratigos J. Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris: a comparative clinical survey of 278 cases. Oral Surg Oral Med Oral Pathol 1982;54:656-62.